- Home
- IBIO vs PROP Comparison
IBIO vs PROP Comparison
Compare IBIO & PROP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | IBIO | PROP |
|---|---|---|
| Founded | 2008 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.0M | 44.9M |
| IPO Year | 2009 | 2008 |
Fundamental Metrics
Financial Performance| Metric | IBIO | PROP |
|---|---|---|
| Price | $0.76 | $0.35 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 2 |
| Target Price | ★ $5.69 | $1.50 |
| AVG Volume (30 Days) | ★ 858.9K | 822.4K |
| Earning Date | 11-11-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 81.71 | 49.06 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $7,939,000.00 |
| Revenue This Year | N/A | $85.81 |
| Revenue Next Year | N/A | $11.47 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 413.59 |
| 52 Week Low | $0.73 | $0.35 |
| 52 Week High | $3.82 | $2.55 |
Technical Indicators
Market Signals| Indicator | IBIO | PROP |
|---|---|---|
| Relative Strength Index (RSI) | 19.34 | 32.87 |
| Support Level | N/A | N/A |
| Resistance Level | $1.52 | $0.59 |
| Average True Range (ATR) | 0.08 | 0.03 |
| MACD | -0.03 | 0.00 |
| Stochastic Oscillator | 6.77 | 6.77 |
Price Performance
Historical ComparisonAbout IBIO iBio Inc.
iBio Inc is a clinical-stage biotechnology company using Artificial Intelligence (AI) for the development of hard-to-drug precision antibodies for obesity, cardiometabolic, and cardiopulmonary diseases. Its product candidate pipeline includes IBIO-610, a monoclonal antibody designed to block Activin E; IBIO-800, a bispecific antibody program targeting myostatin, growth differentiation factor 11 (GDF11), and Activin A; IBIO-600; Amylin Antibody; and Target 4, in different stages of development, being developed as potential therapies for obesity and cardiometabolic disease. The company operates as one reportable segment, which is that of a biotechnology company leveraging AI and ML for the development of hard-to-drug precision antibodies.
About PROP Prairie Operating Co.
Prairie Operating Co is an independent oil and natural gas company focused on the acquisition and development of crude oil, natural gas, and natural gas liquids (NGLs). Its assets and operations are located in the oil region of rural Weld County, Colorado, within the Denver-Julesburg Basin in Colorado (the DJ Basin). The company generates maximum revenue from crude oil sales, and the rest from the sale of natural gas and natural gas liquids.